Citations

Mayo Clinic

Showing 10 of 108551 citations.

Clicking Eyelids: A New Finding of Prostaglandin‐Associated Periorbitopathy
Skorin, Leonid , Dailey, Kathryn H.

Optometry and Vision Science | April 19, 2016 | Volume: 93 | Issue: 7 | Pages: 779-781

10.1097/opx.0000000000000862 | PMID 27055061 Get It

ABSTRACT Supplemental digital content is available in the text. Purpose To present and discuss a case representing both a new sign and symptom of prostaglandin‐associated periorbitopathy. Case Report An 83‐year‐old female patient presented for a 6‐month glaucoma follow‐up in July 2013 with no specific visual or comfort complaints. The patient had a 14‐year history of bilateral primary open angle glaucoma and a 13‐year history of once daily bimatoprost use in both eyes. Evaluation at previous examinations revealed long eyelashes, tight eyelids, small palpebral fissures, and deepening of the upper eyelid sulcus. During slit‐lamp examination of the anterior segment, it was noted that the patient’s eyelids clicked intermittently when she blinked. The patient had not previously noticed the clicking and it was determined to be present in each eye individually. The eyelid clicking has been noted to be present in every follow‐up examination since it was discovered in July 2013. Conclusions Prostaglandin‐associated periorbitopathy and the resulting cosmetic effects noticed visually by patients are well documented. Our case represents a new audible sign and symptom that may be found with prostaglandin‐associated periorbitopathy but has not to our knowledge been reported in the literature.
AngioJet™ thrombolysis of SVC thrombosis after orthotopic heart transplantation: A case report
Sessions, Kristen L., Anderson, Jason H. , Johnson, Jonathan N. , Taggart, Nathaniel W. , Taggart, Nathaniel W , Anderson, Jason

Pediatric Transplantation | April 19, 2016 | Volume: 20 | Issue: 5 | Pages: 723-726

10.1111/petr.12715 | PMID 27090499 Get It

AbstractSVC obstruction is a rare acute complication after bicaval cardiac transplantation and can be catastrophic for the patient. Herein, we report the case of a child who developed SVC thrombosis causing acute SVC syndrome nine days after heart transplantation. Thrombolysis was successfully performed using the AngioJet™ system and subsequent balloon angioplasty with re‐establishment of flow. This procedure allowed for revascularization without repeat sternotomy or stent implantation. The patient is well without recurrence at last follow‐up.
Initial presentation of CNS-restricted acute lymphoblastic B cell leukaemia as peripheral polyneuropathy
Ramos, Guilherme Piovezani , Chen, Dong , Pardanani, Animesh , Piovezani Ramos, Guilherme, Villasboas Bisneto, Jose C, Villasboas, José C. , Chen, Dong , Ramos, Guilherme P

BMJ Case Reports | April 19, 2016 | Volume: 2016 | Issue: No issue available | Pages: bcr2016214645

10.1136/bcr-2016-214645 | PMID 27095809 Get It

We report a case of a 58-year-old woman who presented with a 1-month course of progressive lower and upper extremity weakness in addition to binocular diplopia. Diagnostic lumbar puncture revealed atypical lymphoid cells with 28% blasts. Immunophenotype was consistent with B cell acute lymphoblastic leukaemia (B-ALL). Further work up showed no systemic involvement but extensive thoracolumbar-sacral leptomeningeal disease. The patient was treated with several courses of intrathecal and systemic chemotherapy followed by craniospinal irradiation for consolidation. There was initial steady improvement in neurological symptoms and leptomeningeal disease, the latter being ascertained through radiological studies and cerebrospinal fluid examination. After 10 months of response, the patient relapsed with central nervous system (CNS) and systemic disease. B-ALL is a rare precursor lymphoid neoplasm that generally presents with systemic disease. While CNS involvement is not uncommon, isolated involvement of this compartment without systemic disease is exceedingly rare.
Sex‐Specific Genetic Variants are Associated With Coronary Endothelial Dysfunction
Yoshino, Satoshi , Cilluffo, Rebecca, Prasad, Megha , Best, Patricia J.M. , Atkinson, Elizabeth J. , Cunningham, Julie M. , Lerman, Lilach O. , de Andrade, Mariza, Aoki, Tatsuo , Andrade, Mariza de , Lerman, Amir

Journal of the American Heart Association | April 19, 2016 | Volume: 5 | Issue: 4 | Pages: No page available

10.1161/jaha.115.002544 | PMID 27091178 Get It

Background Endothelial dysfunction is an early stage of atherosclerosis. Single‐nucleotide polymorphisms ( SNP s) have been associated with vascular dysfunction, cardiac events, and coronary artery remodeling. We aimed to detect SNP s associated with endothelial dysfunction and determine whether these associations are sex specific. Methods and Results Six hundred forty‐three subjects without significant obstructive coronary artery disease underwent invasive coronary endothelial function assessment. We collected data from 1536 SNP s that had previously been associated with vasoreactivity, angiogenesis, inflammation, artery calcification, atherosclerotic risk factors, insulin resistance, hormone levels, blood coagulability, or with coronary heart disease. Coronary vascular reactivity was assessed by the percent change in coronary artery diameter ≤ −20% after an intracoronary bolus injection of acetylcholine on invasive coronary physiology study. SNP s significantly associated with coronary epicardial endothelial dysfunction were ADORA 1 , KCNQ 1 , and DNAJC 4 in the whole cohort, LPA , MYBPH , ADORA 3 , and PON 1 in women and KIF 6 and NFKB 1 in men ( P <0.01). Conclusions We have identified several significant SNP s that are associated with an increased risk of coronary endothelial dysfunction. These associations appear to be sex specific and may explain gender‐related differences in development of atherosclerosis.
Hypothalamic hamartoma with neurofibrillary tangles
Yamada, Seiji , Wood, Christopher P. , Shah, Jawad , Vida, Jonathan, Parisi, Joseph E. , Jentoft, Mark E.

Neuropathology | April 19, 2016 | Volume: 36 | Issue: 5 | Pages: 480-484

10.1111/neup.12296 | PMID 27090596 Get It

Hypothalamic hamartomas are rare tumors that typically present in childhood, often with gelastic seizures, precocious puberty, or as a manifestation of Pallister‑Hall syndrome. Neurofibrillary tangles are cytoplasmic aggregates of hyperphosphorylated tau that are best recognized in Alzheimer disease, other tau‐associated neurodegenerative diseases, or as part of aging, but occasionally may be seen in low‐grade neoplasms with a ganglion cell component as gangliocytoma or ganglioglioma. Herein, we report a case of hypothalamic hamartoma with neurofibrillary tangles.
Long-Term Outcomes of Kidney Transplant Recipients with Bladder Dysfunction: A Single-Center Study
Srinivasan, Dushyanth , Stoffel, John T. , Mathur, Amit K. , Kapeles, Steven , Bradley, Kori, Sung, Randall S. , Stoffel, John T

Annals of Transplantation | April 19, 2016 | Volume: 21 | Issue: No issue available | Pages: 222-234

10.12659/aot.895975 | PMID 27090659 Get It

Testing of evaluation bias for progression free survival endpoint in oncology clinical trials
Sun, Yan , Wu, Wenting , Sun, Yan , Sargent, Daniel J , Sargent, Daniel J.

Statistics in Medicine | April 19, 2016 | Volume: 35 | Issue: 22 | Pages: 3923-3932

10.1002/sim.6963 | PMID 27089832 Get It

Progression‐free survival is an increasingly popular end point in oncology clinical trials. A complete blinded independent central review (BICR) is often required by regulators in an attempt to reduce the bias in progression‐free survival (PFS) assessment. In this paper, we propose a new methodology that uses a sample‐based BICR as an audit tool to decide whether a complete BICR is needed. More specifically, we propose a new index, the differential risk, to measure the reading discordance pattern, and develop a corresponding hypothesis testing procedure to decide whether the bias in local evaluation is acceptable. Simulation results demonstrate that our new index is sensitive to the change of discordance pattern; type I error is well controlled in the hypothesis testing procedure, and the calculated sample size provides the desired power. Copyright © 2016 John Wiley & Sons, Ltd.
α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
Guella, Ilaria, Evans, Daniel M. , Szu‐Tu, Chelsea , Nosova, Ekaterina , Bortnick, Stephanie, Group, SNCA Cognition Study, Goldman, Jennifer G. , Dalrymple‐Alford, John C. , Geurtsen, Gert J. , Litvan, Irene , Ross, Owen A. , Middleton, Lefkos , Farrer, Matthew J. , Group, SNCA Cognition Study, Parkkinen, Laura , Goldman, Jennifer G , Ross, Owen A , Dalrymple-Alford, John C , Geurtsen, Gert J , Litvan, Irene

Annals of Neurology | April 19, 2016 | Volume: 79 | Issue: 6 | Pages: 991-999

10.1002/ana.24664 | PMID 27091628 Get It

ObjectiveThe relationship between Parkinson disease (PD), PD with dementia (PDD), and dementia with Lewy bodies (DLB) has long been debated. Although PD is primarily considered a motor disorder, cognitive impairment is often present at diagnosis, and only ∼20% of patients remain cognitively intact in the long term. Alpha‐synuclein (SNCA) was first implicated in the pathogenesis of the disease when point mutations and locus multiplications were identified in familial parkinsonism with dementia. In worldwide populations, SNCA genetic variability remains the most reproducible risk factor for idiopathic PD. However, few investigators have looked at SNCA variability in terms of cognitive outcomes.MethodsWe have used targeted high‐throughput sequencing to characterize the 135kb SNCA locus in a large multinational cohort of patients with PD, PDD, and DLB and healthy controls.ResultsAn analysis of 43 tagging single nucleotide polymorphisms across the SNCA locus shows 2 distinct association profiles for symptoms of parkinsonism and/or dementia, respectively, toward the 3′ or the 5′ of the SNCA gene. In addition, we define a specific haplotype in intron 4 that is directly associated with PDD. The PDD risk haplotype has been interrogated at single nucleotide resolution and is uniquely tagged by an expanded TTTCn repeat.InterpretationOur data show that PD, PDD, and DLB, rather than a disease continuum, have distinct genetic etiologies albeit within one genomic locus. Such results may serve as prognostic biomarkers to these disorders, to inform physicians and patients, and to assist in the design and stratification of clinical trials aimed at disease modification. Ann Neurol 2016;79:991–999
Transition from childhood to adulthood in coeliac disease: the Prague consensus report
Agréus, Lars , Ciacci, Carolina , Crowe, Sheila E., Geller, Marilyn G. , Green, Peter H.R. , Hill, Ivor D., Hungin, A. P. S. , Koletzko, Sibylle , Koltai, Tunde, Mearin, M. Luisa, Reilly, Norelle R., Walker, Marjorie M. , Sanders, David S. , Troncone, Riccardo , Husby, Steffen , Ludvigsson, Jonas F. , Lundin, Knut E. A. , Murray, Joseph A. , Shamir, Raanan , Ciacci, Carolina

Gut | April 18, 2016 | Volume: 65 | Issue: 8 | Pages: 1242-1251

10.1136/gutjnl-2016-311574 | PMID 27196596 Get It

The process of transition from childhood to adulthood is characterised by physical, mental and psychosocial development. Data on the transition and transfer of care in adolescents/young adults with coeliac disease (CD) are scarce. In this paper, 17 physicians from 10 countries (Sweden, Italy, the USA, Germany, Norway, the Netherlands, Australia, Britain, Israel and Denmark) and two representatives from patient organisations (Association of European Coeliac Societies and the US Celiac Disease Foundation) examined the literature on transition from childhood to adulthood in CD. Medline (Ovid) and EMBASE were searched between 1900 and September 2015. Evidence in retrieved reports was evaluated using the Grading of Recommendation Assessment, Development and Evaluation method. The current consensus report aims to help healthcare personnel manage CD in the adolescent and young adult and provide optimal care and transition into adult healthcare for patients with this disease. In adolescence, patients with CD should gradually assume exclusive responsibility for their care, although parental support is still important. Dietary adherence and consequences of non-adherence should be discussed during transition. In most adolescents and young adults, routine small intestinal biopsy is not needed to reconfirm a childhood diagnosis of CD based on European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) or North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) criteria, but a biopsy may be considered where paediatric diagnostic criteria have not been fulfilled, such as, in a patient without biopsy at diagnosis, additional serology (endomysium antibody) has not been performed to confirm 10-fold positivity of tissue transglutaminase antibodies or when a no biopsy strategy has been adopted in an asymptomatic child.